Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

Carl D. Atkins; Mark Rosenthal; Alfredo Berruti; Marcello Tucci; Carlo Terrone; Roberto Mario Scarpa; Alberto Angeli; Luigi Dogliotti; Fred Saad; Donald M. Gleason; Robin Murray; J. Allen Goas; Bee Chen

doi:10.1093/jnci/95.4.332

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

Carl D. Atkins
, Mark Rosenthal
, Alfredo Berruti
, Marcello Tucci
, Carlo Terrone
, Roberto Mario Scarpa
, Alberto Angeli
, Luigi Dogliotti
, Fred Saad
, Donald M. Gleason
, Robin Murray
, J. Allen Goas
, Bee Chen

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	332-333
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	95
Issue number	4
DOIs	https://doi.org/10.1093/jnci/95.4.332
Publication status	Published - 19 Feb 2003
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/jnci/95.4.332

Cite this

Atkins, C. D., Rosenthal, M., Berruti, A., Tucci, M., Terrone, C., Scarpa, R. M., Angeli, A., Dogliotti, L., Saad, F., Gleason, D. M., Murray, R., Goas, J. A., & Chen, B. (2003). Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]. Journal of the National Cancer Institute, 95(4), 332-333. https://doi.org/10.1093/jnci/95.4.332

@article{44cdafebd6694381a3c84005105471f3,

title = "Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]",

author = "Atkins, \{Carl D.\} and Mark Rosenthal and Alfredo Berruti and Marcello Tucci and Carlo Terrone and Scarpa, \{Roberto Mario\} and Alberto Angeli and Luigi Dogliotti and Fred Saad and Gleason, \{Donald M.\} and Robin Murray and Goas, \{J. Allen\} and Bee Chen",

year = "2003",

month = feb,

day = "19",

doi = "10.1093/jnci/95.4.332",

language = "English",

volume = "95",

pages = "332--333",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "4",

}

Atkins, CD, Rosenthal, M, Berruti, A, Tucci, M, Terrone, C, Scarpa, RM, Angeli, A, Dogliotti, L, Saad, F, Gleason, DM, Murray, R, Goas, JA & Chen, B 2003, 'Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]', Journal of the National Cancer Institute, vol. 95, no. 4, pp. 332-333. https://doi.org/10.1093/jnci/95.4.332

TY - JOUR

T1 - Re

T2 - A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

AU - Atkins, Carl D.

AU - Rosenthal, Mark

AU - Berruti, Alfredo

AU - Tucci, Marcello

AU - Terrone, Carlo

AU - Scarpa, Roberto Mario

AU - Angeli, Alberto

AU - Dogliotti, Luigi

AU - Saad, Fred

AU - Gleason, Donald M.

AU - Murray, Robin

AU - Goas, J. Allen

AU - Chen, Bee

PY - 2003/2/19

Y1 - 2003/2/19

UR - https://www.scopus.com/pages/publications/0037453895

U2 - 10.1093/jnci/95.4.332

DO - 10.1093/jnci/95.4.332

M3 - Letter

SN - 0027-8874

VL - 95

SP - 332

EP - 333

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 4

ER -

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

UN SDGs

Access to Document

Other files and links

Cite this